Federal and Provincial Proof of Principle Programs Support Translational Technology Development

TORONTO (August 16, 2010) – MaRS Innovation (MI) is pleased to announce that translational funding to support product development for early… Read More »

MaRS Innovation establishes co-managed fund with Johnson & Johnson

TORONTO (August 9, 2010) – MaRS Innovation (MI) has signed a co-funding agreement with the Johnson & Johnson Corporate Office of… Read More »

MaRS Innovation and Sunnybrook Health Sciences Centre Partner to Develop Four Exciting Medical Discoveries

TORONTO (March 23, 2010) — MaRS Innovation and Sunnybrook Health Sciences Centre have entered into their first set of agreements… Read More »

CIHR Commercialization Program funds insulin-alternative stem cell technology and nicotine addiction drug therapy

TORONTO (March 2, 2010) — MaRS Innovation is delighted to announce that two of its commercialization projects — notably an… Read More »

Leading-edge therapy targets brain chemistry of addiction

TORONTO (Dec. 17, 2009) — Grappling with nicotine addiction is never easy, but a new drug therapy — developed by Dr. Fang… Read More »

MaRS Innovation and CDRD Announce Strategic Collaboration

TORONTO, ON and VANCOUVER, BC (November 30, 2009) — MaRS Innovation and the Centre for Drug Research and Development (CDRD) are… Read More »

Physicist pairs with pharmaceutical scientist to design nano-particles for cancer imaging

TORONTO (November 19, 2009) — In the drive to improve early detection and treatment of cancer, a pair of Toronto scientists… Read More »

MaRS Innovation selects Diabetic Wound Healing Technology from The University of Toronto as its second commercialization opportunity

TORONTO (June 30, 2009) — MaRS Innovation and The University of Toronto (U of T) are pleased to announce that they… Read More »

MaRS Innovation selects umbilical cord stem cell technology from Samuel Lunenfeld Research Institute of Mount Sinai Hospital as its first commercialization opportunity

TORONTO (June 29, 2009) — MaRS Innovation and the Samuel Lunenfeld Research Institute of Mount Sinai Hospital are pleased to announce… Read More »